The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
KEYNOTE-057: Phase 2 study of pembrolizumab for patients (pts) with Bacillus Calmette Guerin (BCG)-unresponsive, high-risk non-muscle-invasive bladder cancer (NMIBC).
 
Ashish M. Kamat
Honoraria - Pacific Edge
Consulting or Advisory Role - Abbott Molecular; Heat Biologics; Merck; Photocure; Sanofi; Spectrum Pharmaceuticals; Telesta Therapeutics; Theralase
Research Funding - FKD Therapies; Heat Biologics; Merck; Photocure
 
Joaquim Bellmunt
Consulting or Advisory Role - Astellas Pharma; Genentech; Merck; Pfizer; Pierre Fabre
Research Funding - Millennium (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Kijoeng Nam
Employment - Merck
 
Maria De Santis
Honoraria - Astellas Pharma; Bayer; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Astellas Pharma; Celgene; Dendreon; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Novartis/Pfizer; Oncogenex; Pierre Fabre; Roche/Genentech; Shionogi; Synthon; Takeda
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Pierre Fabre; Takeda
Research Funding - Pierre Fabre
Travel, Accommodations, Expenses - Bayer; Sanofi
 
Robert Dreicer
Honoraria - Astellas Pharma
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; BIND Biosciences; Dendreon; Medivation; Merck; Millennium; Roche
Research Funding - Progenics (Inst)
 
Noah M. Hahn
Honoraria - D3 Oncology Solutions
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Medivation; Merck; Oncogenex
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Merck (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst)
 
Rodolfo F. Perini
Employment - Merck
 
Arlene O. Siefker-Radtke
Consulting or Advisory Role - Eisai; Genentech; Janssen; Merck; NCCN; Threshold Pharmaceuticals
Speakers' Bureau - Genentech
Research Funding - Genentech; Michael and Sherry Sutton Fund for Urothelial Cancer; Millennium; NIH
Patents, Royalties, Other Intellectual Property - Methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer.
 
Guru Sonpavde
Consulting or Advisory Role - Agensys; Argos Therapeutics; Bayer; Genentech; Merck; Novartis; Pfizer; Sanofi
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Onyx (Inst)
 
Ronald De Wit
Honoraria - Lilly; Merck Sharp & Dohme; Roche/Genentech; Sanofi
Consulting or Advisory Role - Lilly; Merck Sharp & Dohme; Roche/Genentech; Sanofi
Research Funding - Sanofi (Inst)
 
Alfred Witjes
Consulting or Advisory Role - IPsen; MEL Pharma; MSD; Photocure; Sanofi Pasteur; Spectrum Pharmaceuticals
Research Funding - Astellas Pharma
 
Stephen Michael Keefe
Employment - Merck Sharp & Dohme
Research Funding - Bristol-Myers Squibb; Cerulean Pharma; Novartis; Pfizer
Travel, Accommodations, Expenses - ASCO
 
Dean F. Bajorin
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Fidia Farmaceutici S. p. A.; Genentech; Lilly; Merck; Novartis; Roche; Roche/Genentech
Research Funding - Amgen (Inst); dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Merck; Roche/Genentech